Hester Biosciences: Announcement under Regulation 30 (LODR)-Change in Management

Pursuant to the Regulation 30 of Listing Regulations Board of Directors of the Company on recommendation from Nomination and Remuneration Committee and Audit Committee appointed Mr. Divyesh Maru as Chief Financial Officer of the Company with effect from 12 November 2024. Brief details on appointment are provided into the disclosure.